1. Home
  2. KFRC vs ENTA Comparison

KFRC vs ENTA Comparison

Compare KFRC & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$29.58

Market Cap

470.6M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.13

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
ENTA
Founded
1962
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.6M
407.5M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
KFRC
ENTA
Price
$29.58
$14.13
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$34.75
$20.40
AVG Volume (30 Days)
251.8K
290.2K
Earning Date
11-03-2025
11-17-2025
Dividend Yield
5.19%
N/A
EPS Growth
N/A
N/A
EPS
2.26
N/A
Revenue
$1,340,771,000.00
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$0.19
P/E Ratio
$13.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$4.09
52 Week High
$61.81
$15.34

Technical Indicators

Market Signals
Indicator
KFRC
ENTA
Relative Strength Index (RSI) 51.58 69.86
Support Level $29.00 $11.89
Resistance Level $30.42 $14.52
Average True Range (ATR) 1.06 0.86
MACD 0.03 0.10
Stochastic Oscillator 71.58 84.75

Price Performance

Historical Comparison
KFRC
ENTA

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: